
Jon E. Angell
Examiner (ID: 3741, Phone: (571)272-0756 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1635, 1637, 1674 |
| Total Applications | 1431 |
| Issued Applications | 721 |
| Pending Applications | 199 |
| Abandoned Applications | 530 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10038216
[patent_doc_number] => 09078911
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => 'Antisense oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 13/369050
[patent_app_country] => US
[patent_app_date] => 2012-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9253
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13369050
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/369050 | Antisense oligonucleotides | Feb 7, 2012 | Issued |
Array
(
[id] => 8198622
[patent_doc_number] => 20120122216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN MODULATION OF SMALL NON-CODING RNAS'
[patent_app_type] => utility
[patent_app_number] => 13/359271
[patent_app_country] => US
[patent_app_date] => 2012-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 136657
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122216.pdf
[firstpage_image] =>[orig_patent_app_number] => 13359271
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/359271 | Oligomeric compounds and compositions for use in modulation of small non-coding RNAs | Jan 25, 2012 | Issued |
Array
(
[id] => 8607138
[patent_doc_number] => 20130012450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Dermatology Related Genetic Diseases'
[patent_app_type] => utility
[patent_app_number] => 13/356363
[patent_app_country] => US
[patent_app_date] => 2012-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9774
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13356363
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/356363 | Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Dermatology Related Genetic Diseases | Jan 22, 2012 | Abandoned |
Array
(
[id] => 8289382
[patent_doc_number] => 20120177701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'COMPOSITIONS COMPRISING IMMUNOSTIMULATORY NUCLEIC ACIDS AND RELATED METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/341325
[patent_app_country] => US
[patent_app_date] => 2011-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 35525
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13341325
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/341325 | COMPOSITIONS COMPRISING IMMUNOSTIMULATORY NUCLEIC ACIDS AND RELATED METHODS | Dec 29, 2011 | Abandoned |
Array
(
[id] => 8183998
[patent_doc_number] => 20120114607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'SAFE LENTIVIRAL VECTORS FOR TARGETED DELIVERY OF MULTIPLE THERAPEUTIC MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 13/333882
[patent_app_country] => US
[patent_app_date] => 2011-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 19252
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20120114607.pdf
[firstpage_image] =>[orig_patent_app_number] => 13333882
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/333882 | Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules | Dec 20, 2011 | Issued |
Array
(
[id] => 8199615
[patent_doc_number] => 20120122963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'LENTIVIRAL TRIPLEX DNA, AND VECTORS AND RECOMBINANT CELLS CONTAINING LENTIVIRAL TRIPLEX DNA'
[patent_app_type] => utility
[patent_app_number] => 13/301147
[patent_app_country] => US
[patent_app_date] => 2011-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17441
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122963.pdf
[firstpage_image] =>[orig_patent_app_number] => 13301147
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/301147 | Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA | Nov 20, 2011 | Issued |
Array
(
[id] => 8981880
[patent_doc_number] => 08512994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA'
[patent_app_type] => utility
[patent_app_number] => 13/301204
[patent_app_country] => US
[patent_app_date] => 2011-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 24
[patent_no_of_words] => 17466
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13301204
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/301204 | Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA | Nov 20, 2011 | Issued |
Array
(
[id] => 7818478
[patent_doc_number] => 20120065098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'METHOD OF PREDICTING CHEMOTHERAPY EFFECTIVENESS IN COLON ADENOCARCINOMA PATIENTS, USING MIR-21'
[patent_app_type] => utility
[patent_app_number] => 13/296545
[patent_app_country] => US
[patent_app_date] => 2011-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 39101
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065098.pdf
[firstpage_image] =>[orig_patent_app_number] => 13296545
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/296545 | METHOD OF PREDICTING CHEMOTHERAPY EFFECTIVENESS IN COLON ADENOCARCINOMA PATIENTS, USING MIR-21 | Nov 14, 2011 | Abandoned |
Array
(
[id] => 8055955
[patent_doc_number] => 20120077699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-103-2'
[patent_app_type] => utility
[patent_app_number] => 13/296291
[patent_app_country] => US
[patent_app_date] => 2011-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 38603
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077699.pdf
[firstpage_image] =>[orig_patent_app_number] => 13296291
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/296291 | Method of diagnosing poor survival prognosis colon cancer using miR-103-2 | Nov 14, 2011 | Issued |
Array
(
[id] => 7807961
[patent_doc_number] => 20120058915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-10a'
[patent_app_type] => utility
[patent_app_number] => 13/296500
[patent_app_country] => US
[patent_app_date] => 2011-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 38605
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058915.pdf
[firstpage_image] =>[orig_patent_app_number] => 13296500
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/296500 | Method of diagnosing poor survival prognosis colon cancer using miR-10a | Nov 14, 2011 | Issued |
Array
(
[id] => 8571462
[patent_doc_number] => 08338106
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Method of diagnosing poor survival prognosis colon cancer using miR-29a'
[patent_app_type] => utility
[patent_app_number] => 13/296448
[patent_app_country] => US
[patent_app_date] => 2011-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 27
[patent_no_of_words] => 38603
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13296448
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/296448 | Method of diagnosing poor survival prognosis colon cancer using miR-29a | Nov 14, 2011 | Issued |
Array
(
[id] => 7807960
[patent_doc_number] => 20120058914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-203'
[patent_app_type] => utility
[patent_app_number] => 13/296371
[patent_app_country] => US
[patent_app_date] => 2011-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 38599
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058914.pdf
[firstpage_image] =>[orig_patent_app_number] => 13296371
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/296371 | Method of diagnosing poor survival prognosis colon cancer using miR-203 | Nov 14, 2011 | Issued |
Array
(
[id] => 7807957
[patent_doc_number] => 20120058911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-181b'
[patent_app_type] => utility
[patent_app_number] => 13/295209
[patent_app_country] => US
[patent_app_date] => 2011-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 38604
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058911.pdf
[firstpage_image] =>[orig_patent_app_number] => 13295209
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/295209 | Method of diagnosing poor survival prognosis colon cancer using miR-181b | Nov 13, 2011 | Issued |
Array
(
[id] => 7807959
[patent_doc_number] => 20120058913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-16b'
[patent_app_type] => utility
[patent_app_number] => 13/295440
[patent_app_country] => US
[patent_app_date] => 2011-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 38600
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058913.pdf
[firstpage_image] =>[orig_patent_app_number] => 13295440
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/295440 | Method of diagnosing poor survival prognosis colon cancer using miR-16b | Nov 13, 2011 | Issued |
Array
(
[id] => 8571459
[patent_doc_number] => 08338103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Method of diagnosing poor survival prognosis colon cancer using miR-106a'
[patent_app_type] => utility
[patent_app_number] => 13/295692
[patent_app_country] => US
[patent_app_date] => 2011-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 32
[patent_no_of_words] => 38601
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13295692
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/295692 | Method of diagnosing poor survival prognosis colon cancer using miR-106a | Nov 13, 2011 | Issued |
Array
(
[id] => 7807958
[patent_doc_number] => 20120058912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING let-7g'
[patent_app_type] => utility
[patent_app_number] => 13/295280
[patent_app_country] => US
[patent_app_date] => 2011-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 38605
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058912.pdf
[firstpage_image] =>[orig_patent_app_number] => 13295280
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/295280 | Method of diagnosing poor survival prognosis colon cancer using let-7g | Nov 13, 2011 | Issued |
Array
(
[id] => 8196944
[patent_doc_number] => 20120121551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'COMPOSITIONS AND METHODS FOR IMMUNOSTIMULATORY RNA OLIGONUCLEOTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/293547
[patent_app_country] => US
[patent_app_date] => 2011-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 73
[patent_no_of_words] => 33340
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20120121551.pdf
[firstpage_image] =>[orig_patent_app_number] => 13293547
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/293547 | COMPOSITIONS AND METHODS FOR IMMUNOSTIMULATORY RNA OLIGONUCLEOTIDES | Nov 9, 2011 | Abandoned |
Array
(
[id] => 8228545
[patent_doc_number] => 20120142755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 13/283508
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11734
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13283508
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/283508 | COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION | Oct 26, 2011 | Abandoned |
Array
(
[id] => 8607114
[patent_doc_number] => 20130012426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For the Treatment of Psoriasis'
[patent_app_type] => utility
[patent_app_number] => 13/273206
[patent_app_country] => US
[patent_app_date] => 2011-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 9231
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13273206
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/273206 | Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For the Treatment of Psoriasis | Oct 12, 2011 | Abandoned |
Array
(
[id] => 9503556
[patent_doc_number] => 08741870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'Axl receptor tyrosine kinase aptamer inhibitor for use in therapy'
[patent_app_type] => utility
[patent_app_number] => 13/876103
[patent_app_country] => US
[patent_app_date] => 2011-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5377
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876103
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/876103 | Axl receptor tyrosine kinase aptamer inhibitor for use in therapy | Oct 9, 2011 | Issued |